ARTICLE | Distillery Therapeutics
Neurology
March 7, 2018 12:47 AM UTC
Cell culture and mouse studies suggest inhibiting necroptosis could help treat PD in patients harboring OPA1 mutations. In three neural progenitor cell lines derived from a patient harboring OPA1 muta...
BCIQ Company Profiles
BCIQ Target Profiles